Latest News

 Filter by Provider

REV Group (REVG) aligns with Peter Lynch's strategy, showing strong earnings growth, a low PEG ratio, high ROE, and minimal debt for sustainable value.

As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Revenues rose to $17.28 billion, and earnings per share clocked in at $2.58. The latter represented a 64% surge year-over-year, and revenues and EPS beat estimates.

The US dollar is beginning the new month on a firm note.

ECARX achieves its first-ever quarterly net profit in Q3 2025, a major milestone that drove a positive market reaction despite a revenue miss.

In a recent note, analysts at Morgan Stanley have highlighted two significant risks that could potentially impact the U.S. stock market in the near future.

Precision BioSciences (DTIL) reported a major Q3 2025 earnings and revenue miss, causing shares to fall. Despite the financial setback, the company highlighted progress in its gene editing pipeline.

BioCryst Q3 2025 results: Earnings beat estimates with $0.06 EPS, but revenue of $159.4M missed forecasts. ORLADEYO sales grew 37%.

After opening the day lower, the benchmark indices continued their upward momentum, ended the session in green.

Karyopharm (KPTI) Q3 2025 results show a revenue beat but an earnings miss. The stock rose pre-market as investors focus on XPOVIO sales growth and key Phase 3 data due in 2026.

Bruker (BRKR) Q3 2025 earnings beat EPS estimates by 31.6%, though revenue slightly missed forecasts. The company also issued updated, more conservative full-year guidance.

AMG Q3 2025 earnings beat EPS estimates at $6.10, but revenue of $528M missed forecasts. The stock rose 1.8% on the profit strength.

Genie Energy Q3 2025 earnings: revenue beat expectations, but EPS missed estimates, sending the stock lower.

Vertex (VERX) Q3 2025 earnings beat EPS estimates but revenue missed forecasts. The tax software firm announced a $150M stock buyback and new CEO from Microsoft.

Amazon.com has apparently just broken resistance around the $242 level. If this level converts into support, a move higher may follow.

Krystal Biotech's Q3 2025 earnings crushed estimates, with EPS of $2.66 and $97.8M revenue. Strong VYJUVEK sales and global expansion in Europe and Japan drive growth.

Axsome Therapeutics Q3 2025 results: Revenue beat expectations with strong product sales, but the company reported a wider-than-expected loss.

Kontoor Brands Q3 2025 earnings beat EPS estimates, raised full-year outlook. Revenue growth driven by Helly Hansen acquisition.

PSEG (PEG) Q3 2025 earnings beat profit forecasts with $1.13 EPS but missed revenue estimates of $2.876B, leading to a cautious market reaction.

XRP (CRYPTO: XRP) has dropped by 5% to $2.40 as hopes for a major rebound rests on the approval of spot XRP ETFs.

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Elon Musk's $1 trillion pay deal is at stake on Nov. 6.

Cleveland-Cliffs shares gained 1.4% to close at $12.43 on Friday while Bristol-Myers Squibb shares gained 1% to close at $46.07.

Gap Inc. presents a compelling value investment case with a low P/E ratio, strong profitability, and a solid financial position, suggesting a potential market undervaluation.

Many investors are overlooking this no-brainer AI play, but that could be a mistake.

The S&P 500 set a new record high of 6,890.89 on Tuesday, 28 October 2025, following a new trade truce between the U.S. and China over the weekend and big deals and earnings among AI companies on Tuesday.

Treasury Secretary Scott Bessent suggested that the Trump administration would need court guidance to disburse emergency funds for the Supplemental Nutrition Assistance Program (SNAP) benefits.

Here are two very different ways to invest in the AI boom for the long term.

Apple stock is up 64% since its April low, but the fundamentals are more vanilla flavored.

Shiba Inu (CRYPTO: SHIB) is down another 6% but is seeing growing recognition from major players, with T. Rowe Price filing for the first U.S.

The latest earnings release had a mix of good and worrisome news for investors in this "Magnificent Seven" stock.

Loews Q3 2025 net income rises to $504M, or $2.43 per share, driven by strong CNA Financial results and Boardwalk growth projects.

Google seems to be in the artificial intelligence winners circle. But it may have to share it with OpenAI. Will Gemini 3 make a difference?

LPL Financial (LPLA) is a top GARP stock with strong revenue & earnings growth, a reasonable P/E ratio, and solid financial health.

Shopify has rallied since the "Instant Checkout" partnership with OpenAI.

AT&T reported third-quarter operating revenues of $30.71 billion. It fell short of the analyst consensus estimate of $30.87 billion.

It would be best to get in before the rest of the market pounces on these opportunities.